A Phase 3 Clinical Trial of GMI-1271 and Decitabine in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Who Are Unfit for Chemotherapy
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Uproleselan-sodium (Primary) ; Decitabine
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 08 Feb 2018 According to a GlycoMimetics media release, Professor Gerwin Huls is the principal investigator at HOVON and Professor of Haematology at University Medical Centre Groningen.
- 08 Feb 2018 According to a GlycoMimetics media release, this trial is expected to start this year and will be conducted in five countries across Europe.
- 08 Feb 2018 According to a GlycoMimetics media release, the company has entered into an agreement with the Haemato Oncology Foundation for Adults in the Netherlands (HOVON) group to initiate clinical trial startup activities for this planned trial.